Great Point Partners LLC Rezolute, Inc. Transaction History
Great Point Partners LLC
- $121 Million
- Q2 2025
A detailed history of Great Point Partners LLC transactions in Rezolute, Inc. stock. As of the latest transaction made, Great Point Partners LLC holds 3,033,462 shares of RZLT stock, worth $18.8 Million. This represents 11.22% of its overall portfolio holdings.
Number of Shares
3,033,462
Previous 833,042
264.14%
Holding current value
$18.8 Million
Previous $2.42 Million
460.21%
% of portfolio
11.22%
Previous 1.49%
Shares
3 transactions
Others Institutions Holding RZLT
# of Institutions
96Shares Held
59.5MCall Options Held
687KPut Options Held
19K-
Federated Hermes, Inc. Pittsburgh, PA14MShares$87 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.02MShares$24.9 Million0.0% of portfolio
-
Blackstone Inc New York, NY3.56MShares$22.1 Million0.08% of portfolio
-
Ubs Group Ag3.04MShares$18.8 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.89MShares$17.9 Million0.02% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $241M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...